MABACUS

Welcome to the Brand page for “MABACUS”, which is offered here for The treatment of libraries of bacteriophages expressing at their surface a monoclonal antibody, and the treatment of bacterieophages isolated from such libraries;libraries of bacteriophages expressing a monoclonal antibody at their surface, bacteriophages isolated from such libraries; human monoclonal antibodies to be used for research, human therapeutics or diagnostics; bacteria; media for culturing bacteriophages;scientific research; medical and biochemical services, in particular the research and identification of bactefieophages; research, development and identification of monoclonal antibodies;.

Its status is currently believed to be active. Its class is unavailable. “MABACUS” is believed to be currently owned by “CRUCELL HOLLAND B.V.”